AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FREMONT, Calif., Dec. 21 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. today announced that it has teamed with Mosaic Health Care Consultants to develop reimbursement strategies and programs for its ovarian tumor triage test.
"The establishment of optimal reimbursement for our ovarian tumor diagnostic program is one crucial aspect of gaining rapid adoption by the medical community," said Gail S. Page, President and CEO of Ciphergen. "Mosaic is an ideal partner for us to work with given their extensive experience helping innovative healthcare diagnostic providers successfully secure reimbursement from public and private payers."
Mosaic specializes in reimbursement, health economics, and outcomes research for pharmaceutical, biotechnology, medical device, and diagnostics clients.…
Source: HighBeam Research, Ciphergen Chooses Mosaic to Develop Broad Reimbursement Strategy for...